These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8875953)

  • 1. Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism.
    Fleischman RA; Gallardo T; Mi X
    J Invest Dermatol; 1996 Nov; 107(5):703-6. PubMed ID: 8875953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
    Fleischman RA
    J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Giebel LB; Holmes SA
    Am J Hum Genet; 1992 Feb; 50(2):261-9. PubMed ID: 1370874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human piebaldism: six novel mutations of the proto-oncogene KIT.
    Syrris P; Heathcote K; Carrozzo R; Devriendt K; Elçioglu N; Garrett C; McEntagart M; Carter ND
    Hum Mutat; 2002 Sep; 20(3):234. PubMed ID: 12204004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Holmes SA; Itin P; Küster W
    J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.
    Spritz RA; Holmes SA; Ramesar R; Greenberg J; Curtis D; Beighton P
    Am J Hum Genet; 1992 Nov; 51(5):1058-65. PubMed ID: 1384325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel KIT missense mutation in one Chinese family with piebaldism.
    Yin XY; Ren YQ; Yang S; Xu SX; Zhou FS; Du WH; Lin D; Wang PG; Zhang SM; Zhang XJ
    Arch Dermatol Res; 2009 Jun; 301(5):387-9. PubMed ID: 19430803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
    Giebel LB; Spritz RA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8696-9. PubMed ID: 1717985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piebaldism with deafness: molecular evidence for an expanded syndrome.
    Spritz RA; Beighton P
    Am J Med Genet; 1998 Jan; 75(1):101-3. PubMed ID: 9450866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism.
    Ezoe K; Holmes SA; Ho L; Bennett CP; Bolognia JL; Brueton L; Burn J; Falabella R; Gatto EM; Ishii N
    Am J Hum Genet; 1995 Jan; 56(1):58-66. PubMed ID: 7529964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of piebaldism in a Tunisian family.
    Kerkeni E; Boubaker S; Sfar S; Bizid M; Besbes H; Bouaziz S; Ghedira N; Amara A; Manoubi W; Gribaa M; Monastiri K
    Pathol Biol (Paris); 2015 Jun; 63(3):113-6. PubMed ID: 25910686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice transgenic for Kit(V620A): recapitulation of piebaldism but not progressive depigmentation seen in humans with this mutation.
    Tosaki H; Kunisada T; Motohashi T; Aoki H; Yoshida H; Kitajima Y
    J Invest Dermatol; 2006 May; 126(5):1111-8. PubMed ID: 16456533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of a novel KIT mutation in a Chinese family affected with piebaldism].
    Wang R; Shu S; Zhang Y; Luo W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):637-40. PubMed ID: 27577211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three novel mutations of the proto-oncogene KIT cause human piebaldism.
    Syrris P; Malik NM; Murday VA; Patton MA; Carter ND; Hughes HE; Metcalfe K
    Am J Med Genet; 2000 Nov; 95(1):79-81. PubMed ID: 11074500
    [No Abstract]   [Full Text] [Related]  

  • 16. KIT-related piebaldism in a Chinese girl.
    Zhu L; Yang C; Zhong W; Huang YQ; Zhang Q; Xu WC; Chen YF
    Am J Med Genet A; 2020 Jun; 182(6):1321-1328. PubMed ID: 32220041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of human piebaldism.
    Spritz RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):137S-140S. PubMed ID: 7525736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New KIT mutations in patients with piebaldism.
    Murakami T; Fukai K; Oiso N; Hosomi N; Kato A; Garganta C; Barnicoat A; Poppelaars F; Aquaron R; Paller AS; Ishii M
    J Dermatol Sci; 2004 Jun; 35(1):29-33. PubMed ID: 15194144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piebaldism with café-au-lait macules resulting from a novel mutation of KIT gene in a three-generation Chinese family.
    Li X; Xing X; Liang X; Song C; Yang J; Ren D; Zhou Y
    Skin Res Technol; 2023 Jun; 29(6):e13352. PubMed ID: 37357653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation of the KIT gene in a Chinese family with piebaldism.
    Wen GD; Zhou C; Yu C; DU J; Xu QX; Liu ZY; Zhang JZ
    Chin Med J (Engl); 2013 Jun; 126(12):2325-8. PubMed ID: 23786947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.